Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma
- 1 August 2000
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (12) , 1514-1521
- https://doi.org/10.1016/s0959-8049(00)00139-8
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Malignant pleural mesotheliomaAnnals of Oncology, 1998
- A Review of Chemotherapy Trials for Malignant MesotheliomaChest, 1998
- Higher doses of α-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesotheliomaEuropean Journal Of Cancer, 1997
- 62 Phase II study of paclitaxel (Taxol®) and cisplatin (CDDP) in advanced pleural malignant mesothelioma (MM)Lung Cancer, 1997
- Chemotherapy in malignant pleural mesothelioma. A review.Journal of Clinical Oncology, 1996
- A Proposed New International TNM Staging System for Malignant Pleural MesotheliomaChest, 1995
- Prevention of Malignant Seeding After Invasive Diagnostic Procedures in Patients With Pleural MesotheliomaChest, 1995
- Continuing increase in mesothelioma mortality in BritainThe Lancet, 1995
- Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.Journal of Clinical Oncology, 1989
- Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers.Journal of Clinical Oncology, 1988